Ftse Mib
33.260,13
0,51%
DAX
19.425,73
0,85%
S&P 500
5.998,74
-0,38%
NASDAQ
19.060,48
-0,60%
Bitcoin
95.752,79
0,10%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Elutia Inc (ELUT) Elutia Inc (ELUT) Notizie

Elutia Inc

ELUT
4,19
0,19 (4,75%)
28 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:10EDGAR2Form 8-K - Current report
14/11/202422:05GLOBEElutia Announces Strong Third Quarter Results, Accelerating..
13/11/202422:05GLOBEElutia to Participate at the Canaccord Genuity MedTech,..
29/10/202421:05GLOBEElutia to Report Third Quarter 2024 Financial Results on..
23/10/202422:05GLOBEElutia to Present at the LD Micro Main Event XVII Conference..
15/10/202412:59EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
03/10/202422:05EDGAR2Form 8-K - Current report
18/9/202414:00GLOBEElutia Announces New Peer Reviewed Publication Highlighting..
06/9/202422:23GLOBEElutia Celebrates First Year
05/9/202422:05GLOBEElutia Announces First Patient Implant of EluPro™, the..
03/9/202422:05GLOBEElutia to Participate in Upcoming Investor Conferences
13/8/202415:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:05GLOBEElutia Announces Second Quarter 2024 Results
07/8/202422:01EDGAR2Form 8-K - Current report
01/8/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:05GLOBEElutia Announces Full Exercise of Warrants Generating $15.7..
31/7/202422:05GLOBEElutia Appoints Ryan Marques, Ph.D., MBA as Vice President..
30/7/202422:05GLOBEElutia to Report Second Quarter 2024 Financial Results on..
11/7/202422:05GLOBEElutia to Present at the Emerging Growth Conference on..
18/6/202422:15EDGAR2Form 8-K - Current report
17/6/202414:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/6/202414:15EDGAR2Form 8-K - Current report
17/6/202414:01GLOBEElutia Announces $13.26 Million Registered Direct Offering
17/6/202414:00GLOBEElutia Announces FDA Clearance of EluPro®: The First..
10/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202423:00EDGAR2Form 8-K - Current report
13/5/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202414:00GLOBEElutia to Showcase BioEnvelope Product Line at Heart Rhythm..
09/5/202423:26EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEElutia Announces First Quarter 2024 Results: SimpliDerm®..
02/5/202422:05GLOBEElutia to Report First Quarter 2024 Financial Results on..
24/4/202422:05GLOBEElutia to Present at the Planet MicroCap Showcase: VEGAS..
11/3/202414:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202422:24EDGAR2Form 8-K - Current report
07/3/202422:05GLOBEElutia Reports Fourth Quarter and Full Year 2023 Financial..
22/2/202422:05GLOBEElutia to Report Fourth Quarter and Full Year 2023 Financial..
14/2/202422:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/202422:30EDGAR2Form 8-K - Current report
25/1/202422:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/1/202423:00EDGAR2Form 8-K - Current report
10/1/202423:00EDGAR2Form 8-K - Current report
10/1/202422:05GLOBEElutia Regains Compliance with Nasdaq Listing Requirements
09/1/202422:17EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:30EDGAR2Form 8-K - Current report
18/12/202314:00GLOBEElutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for..
08/12/202322:04EDGAR2Form 8-K - Current report
Apertura: 4,06 Min: 4,06 Max: 4,77
Chiusura: 4,00

La tua Cronologia

NASDAQ
ELUT
Elutia
LSE
94HT
Anz Bank 30
USOTC
UHOIF
Ushio (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network